Literature DB >> 20050929

Long-term evaluation of chromosomal breakages after radioisotope synovectomy for treatment of target joints in patients with haemophilia.

K Kavakli1, O Cogulu, S Aydogdu, H Ozkiliç, B Durmaz, O Kirbiyik, F Ozkinay, C Balkan, D Karapinar, Y Ay.   

Abstract

Radioisotope synovectomy (RS) is defined as the intra-articular injection of radioisotopic agents with the aim of fibrosis on hypertrophic synovium in the target joint. The aim of this study was to investigate genotoxic effects on lymphocytes and malign transformation induced by Yttrium(90) (Y(90)) and Rhenium(186) (Re(186)) in children with haemophilia undergone RS. Forty haemophilia patients were enrolled. The mean age was 16.4 +/- 6.2 years (range: 8-40). Y(90) was used for knees, Re(186) was used for other joints. For safety, cytogenetic analysis was performed to determine potential chromosomal changes after RS procedure at three different time points as prior to procedure, 3rd day and 90th day. For the stimulation of chromosomal breakages, diepoxybutane was used (DEB test). Chromosomal breakages (CBs) were found in 23 patients (67.6%) prior to RS. We have found CBs additionally in nine of 11 patients who had no CBs prior to RS after 3 days of radioisotope exposure. At that time, the patients who had CBs were 29 (85.2%). At day 90, only 21 patients revealed (61.7%) CBs. The mean frequency of CBs slightly but not significantly increased in the 3rd day. However, there was a significant decreasing trend between 3rd and 90th days. Radioisotope synovectomy with Y(90) and Re(186) does not seem to induce the genotoxic effects significantly on peripheral blood lymphocytes. However, CBs even after one year in the re-evaluation of four patients, significant decrease in the number of CBs between the 3rd and 90th days and de novo CBs after exposure may be accepted as warning signals for young population. It should also be pointed out that families and patients be informed properly related with historical and potential dangers of radioisotopic agents.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20050929     DOI: 10.1111/j.1365-2516.2009.02167.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  4 in total

Review 1.  Progress in intra-articular therapy.

Authors:  Christopher H Evans; Virginia B Kraus; Lori A Setton
Journal:  Nat Rev Rheumatol       Date:  2013-11-05       Impact factor: 20.543

2.  The EANM guideline for radiosynoviorthesis.

Authors:  W U Kampen; B Boddenberg-Pätzold; M Fischer; M Gabriel; R Klett; M Konijnenberg; E Kresnik; H Lellouche; F Paycha; L Terslev; C Turkmen; F van der Zant; L Antunovic; E Panagiotidis; G Gnanasegaran; T Kuwert; T Van den Wyngaert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-10-20       Impact factor: 9.236

3.  Radiosynovectomy in hemophilic synovitis.

Authors:  Zehra Ozcan
Journal:  Mol Imaging Radionucl Ther       Date:  2014-02-05

4.  Comparison of arthroscopic, radioactive and combined synovectomy in the treatment of chronic non-specific knee synovitis.

Authors:  Ibrahim Karaman; Ahmet Guney; Fatih Dogar; Ibrahim Halil Kafadar; Okkes Bilal; Mithat Oner; Mustafa Kula
Journal:  Med Princ Pract       Date:  2014-08-29       Impact factor: 1.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.